Sort

Search

22/09/2022 Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Dohner, H, Wei, AH, Appelbaum, FR, Craddock, C, DiNardo, CD, Dombret, H, Ebert, BL, Fenaux, P, Godley, LA, Hasserjian, RP, Larson, RA, Levine, RL, Miyazaki, Y, Niederwieser, D, Ossenkoppele, G, Rollig, C, Sierra, J, Stein, EM, Tallman, MS, Tien, HF, Wang, JX, Wierzbowska, A, Lowenberg, B. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. BLOOD. 2022; 140(12)DOI:10.1182/blood.2022016867. PMID:35797463. IF:20.300(Q1/1D).
21/09/2022 Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease
Casado-Llombart, S, Velasco-de Andres, M, Catala, C, Leyton-Pereira, A, Gutierrez-Cozar, R, Suarez, B, Armiger, N, Carreras, E, Esteller, M, Ricart, E, Ordas, I, Gisbert, JP, Chaparro, M, Esteve, M, Marquez, L, Busquets, D, Iglesias, E, Garcia-Planella, E, Martin-Arranz, MD, Lohmann, J, Ayata, CK, Niess, JH, Engel, P, Panes, J, Salas, A, Domenech, E, Lozano, F. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.966184. PMID:36211446. IF:7.300(Q1/3D).
20/09/2022 An International Perspective on Preceding Infections in Guillain-Barre Syndrome The IGOS-1000 Cohort
Leonhard, SE, van der Eijk, AA, Andersen, H, Antonini, G, Arends, S, Attarian, S, Barroso, FA, Bateman, KJ, Batstra, MR, Benedetti, L, van den Berg, B, Van den Bergh, P, Burmann, J, Busby, M, Casasnovas, C, Cornblath, DR, Davidson, A, Doets, AY, van Doorn, PA, de la Cour, CD, Feasby, TE, Fehmi, J, Garcia-Sobrino, T, Goldstein, JM, Gorson, KC, Granit, V, Hadden, RDM, Harbo, T, Hartung, HP, Hasan, I, Holbech, JV, Holt, JKL, Jahan, I, Islam, Z, Karafiath, S, Katzberg, HD, Kleyweg, RP, Kolb, N, Kuitwaard, K, Kuwahara, M, Kusunoki, S, Luijten, LWG, Kuwabara, S, Pan, EL, Lehmann, HC, Maas, M, Martin-Aguilar, L, Al Miller, J, Mohammad, QD, Monges, S, Nedkova-Hristova, V, Nobile-Orazio, E, Pardo, J, Pereon, Y, Querol, L, Reisin, R, Van Rijs, W, Rinaldi, S, Roberts, RC, Roodbol, J, Shahrizaila, N, Sindrup, SH, Stein, B, Cheng-Yin, T, Tankisi, H, Tio-Gillen, AP, Tous, MJS, Verboon, C, Vermeij, FH, Visser, LH, Huizinga, R, Willison, HJ, Jacobs, BC. An International Perspective on Preceding Infections in Guillain-Barre Syndrome The IGOS-1000 Cohort. NEUROLOGY. 2022; 99(12)DOI:10.1212/WNL.0000000000200885. PMID:35981895. IF:9.900(Q1/1D).
16/09/2022 Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain
Biagetti, B, Iglesias, P, Villar-Taibo, R, Moure, MD, Paja, M, Araujo-Castro, M, Ares, J, Alvarez-Escola, C, Vicente, A, Guivernau, EA, Novoa-Testa, I, Perez, FG, Camara, R, Lecumberri, B, Gomez, CG, Bernabeu, I, Manjon, L, Gaztambide, S, Cordido, F, Webb, SM, Menendez-Torre, EL, Diez, JJ, Simo, R, Puig-Domingo, M. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.984877. PMID:36187107. IF:5.200(Q1/3D).